Modern sugarcanes are polyploid interspecific hybrids, combining high sugar content from Saccharum officinarum with hardiness, disease resistance and ratooning of Saccharum spontaneum. Sequencing of a haploid S. spontaneum, AP85-441, facilitated the assembly of 32 pseudo-chromosomes comprising 8 homologous groups of 4 members each, bearing 35,525 genes with alleles defined. The reduction of basic chromosome number from 10 to 8 in S. spontaneum was caused by fissions of 2 ancestral chromosomes followed by translocations to 4 chromosomes. Surprisingly, 80% of nucleotide binding site-encoding genes associated with disease resistance are located in 4 rearranged chromosomes and 51% of those in rearranged regions. Resequencing of 64 S. spontaneum genomes identified balancing selection in rearranged regions, maintaining their diversity. Introgressed S. spontaneum chromosomes in modern sugarcanes are randomly distributed in AP85-441 genome, indicating random recombination among homologs in different S. spontaneum accessions. The allele-defined Saccharum genome offers new knowledge and resources to accelerate sugarcane improvement.
Inferring molecular networks is a central challenge in computational biology. However, it has remained unclear whether causal, rather than merely correlational, relationships can be effectively inferred in complex biological settings. Here we describe the HPN-DREAM network inference challenge that focused on learning causal influences in signaling networks. We used phosphoprotein data from cancer cell lines as well as in silico data from a nonlinear dynamical model. Using the phosphoprotein data, we scored more than 2,000 networks submitted by challenge participants. The networks spanned 32 biological contexts and were scored in terms of causal validity with respect to unseen interventional data. A number of approaches were effective and incorporating known biology was generally advantageous. Additional sub-challenges considered time-course prediction and visualization. Our results constitute the most comprehensive assessment of causal network inference in a mammalian setting carried out to date and suggest that learning causal relationships may be feasible in complex settings such as disease states. Furthermore, our scoring approach provides a practical way to empirically assess the causal validity of inferred molecular networks.
Batch Normalization (BN) is ubiquitously employed for accelerating neural network training and improving the generalization capability by performing standardization within mini-batches. Decorrelated Batch Normalization (DBN) further boosts the above effectiveness by whitening. However, DBN relies heavily on either a large batch size, or eigendecomposition that suffers from poor efficiency on GPUs. We propose Iterative Normalization (IterNorm), which employs Newtons iterations for much more efficient whitening, while simultaneously avoiding the eigen-decomposition. Furthermore, we develop a comprehensive study to show IterNorm has better trade-off between optimization and generalization, with theoretical and experimental support. To this end, we exclusively introduce Stochastic Normalization Disturbance (SND), which measures the inherent stochastic uncertainty of samples when applied to normalization operations. With the support of SND, we provide natural explanations to several phenomena from the perspective of optimization, e.g., why group-wise whitening of DBN generally outperforms full-whitening and why the accuracy of BN degenerates with reduced batch sizes. We demonstrate the consistently improved performance of IterNorm with extensive experiments on CIFAR-10 and ImageNet over BN and DBN.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.